| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
|
Moh Moh, Myint Aung
|
|
2019
|
16 |
2 |
p. 186-195
|
article
|
| 2 |
Bariatric surgery as a model to explore the basis and consequences of the Reaven hypothesis: Small, dense low-density lipoprotein and interleukin-6
|
Adam, Safwaan
|
|
2019
|
16 |
2 |
p. 144-152
|
article
|
| 3 |
Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trial
|
Kumar, Anirudh
|
|
2019
|
16 |
2 |
p. 171-177
|
article
|
| 4 |
Effects of magnitude of visceral adipose tissue reduction: Impact on insulin resistance, hyperleptinemia and cardiometabolic risk in adolescents with obesity after long-term weight-loss therapy
|
Campos, Raquel Munhoz da Silveira
|
|
2019
|
16 |
2 |
p. 196-206
|
article
|
| 5 |
Effects of obesity on insulin: insulin-like growth factor 1 hybrid receptor expression and Akt phosphorylation in conduit and resistance arteries
|
Mughal, Romana S
|
|
2019
|
16 |
2 |
p. 160-170
|
article
|
| 6 |
Gerald Reaven: A man for our times
|
Handelsman, Yehuda
|
|
2019
|
16 |
2 |
p. 113-115
|
article
|
| 7 |
Glycaemic variation is a predictor of all-cause mortality in the Veteran Affairs Diabetes Trial
|
Zhou, Jin J
|
|
2019
|
16 |
2 |
p. 178-185
|
article
|
| 8 |
Impact of race/ethnicity on insulin resistance and hypertriglyceridaemia
|
Raygor, Viraj
|
|
2019
|
16 |
2 |
p. 153-159
|
article
|
| 9 |
Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift
|
Nolan, Christopher J
|
|
2019
|
16 |
2 |
p. 118-127
|
article
|
| 10 |
Insulin resistance: Impact on therapeutic developments in diabetes
|
Bailey, Clifford J
|
|
2019
|
16 |
2 |
p. 128-132
|
article
|
| 11 |
Personal Memories
|
|
|
2019
|
16 |
2 |
p. 207-209
|
article
|
| 12 |
Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes
|
DeFronzo, Ralph A
|
|
2019
|
16 |
2 |
p. 133-143
|
article
|
| 13 |
The Reaven syndrome: An historical perspective
|
Soran, Handrean
|
|
2019
|
16 |
2 |
p. 116-117
|
article
|
Journal description